- Home
- APLT vs APPS Comparison
APLT vs APPS Comparison
Compare APLT & APPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- APPS
- Stock Information
- Founded
- APLT 2016
- APPS 2007
- Country
- APLT United States
- APPS United States
- Employees
- APLT N/A
- APPS N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- APPS Multi-Sector Companies
- Sector
- APLT Health Care
- APPS Miscellaneous
- Exchange
- APLT Nasdaq
- APPS Nasdaq
- Market Cap
- APLT 140.8M
- APPS 153.5M
- IPO Year
- APLT 2019
- APPS N/A
- Fundamental
- Price
- APLT $1.10
- APPS $1.46
- Analyst Decision
- APLT Buy
- APPS Hold
- Analyst Count
- APLT 6
- APPS 4
- Target Price
- APLT $6.60
- APPS $2.38
- AVG Volume (30 Days)
- APLT 10.8M
- APPS 2.6M
- Earning Date
- APLT 11-07-2024
- APPS 02-05-2025
- Dividend Yield
- APLT N/A
- APPS N/A
- EPS Growth
- APLT N/A
- APPS N/A
- EPS
- APLT N/A
- APPS N/A
- Revenue
- APLT N/A
- APPS $491,574,000.00
- Revenue This Year
- APLT N/A
- APPS N/A
- Revenue Next Year
- APLT $5,117.00
- APPS $9.20
- P/E Ratio
- APLT N/A
- APPS N/A
- Revenue Growth
- APLT N/A
- APPS N/A
- 52 Week Low
- APLT $1.03
- APPS $1.18
- 52 Week High
- APLT $10.62
- APPS $7.33
- Technical
- Relative Strength Index (RSI)
- APLT 17.64
- APPS 38.12
- Support Level
- APLT $1.03
- APPS $1.40
- Resistance Level
- APLT $1.37
- APPS $1.48
- Average True Range (ATR)
- APLT 0.33
- APPS 0.09
- MACD
- APLT -0.15
- APPS 0.06
- Stochastic Oscillator
- APLT 0.75
- APPS 25.00
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.